EarningsQ2 2024 Earnings Report

Alnylam Pharma (ALNY) Q2 2024 Earnings Report

0 Followers

MX:ALNY Q2 2024 EPS Results

Actual EPS-$2.39

Consensus EPS-$19.62

Beat/MissBeat by +$17.23

One Year Ago EPS-$40.64

Actual Revenue$12.13B

Expected Revenue$8.22B

Beat/MissBeat by +$3.91B

YoY Revenue Growth+107.00%

QuarterQ2 2024

Date08/01/2024

TimeBefore Open

Conference CallThursday, August 1, 2024

MX:ALNY Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:ALNY Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	32.15 / -	33.84	―
Jul 30, 2026	2026 (Q2)	29.98 / 22.25	-9.379	337.25% (+31.63)
Apr 30, 2026	2026 (Q1)	16.04 / 27.77	-8.092	443.18% (+35.86)
Feb 12, 2026	2025 (Q4)	21.15 / 15.08	-11.954	226.15% (+27.03)
Oct 30, 2025	2025 (Q3)	10.32 / 33.84	-16	311.49% (+49.84)
Jul 31, 2025	2025 (Q2)	-10.00 / -9.38	-2.391	-292.31% (-6.99)
May 01, 2025	2025 (Q1)	-16.37 / -8.09	-9.563	15.38% (+1.47)
Feb 13, 2025	2024 (Q4)	-10.89 / -11.95	-20.23	40.91% (+8.28)
Oct 31, 2024	2024 (Q3)	-16.86 / -16.00	21.15	-175.65% (-37.15)
Aug 01, 2024	2024 (Q2)	-19.62 / -2.39	-40.644	94.12% (+38.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed